TER vs UPB · P/E 76, rev $2.82B vs rev $2.4M
Teradyne Inc (TER) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
TER currently screens at market cap $63.96B and trailing P/E 75.7. UPB currently screens at market cap $407.3M.
Not investment advice. Open the TER and UPB stock pages for the full models.
Not investment advice.